mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.5 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.5 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.03 |
0.5 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.5 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.5 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.047 |
0.5 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |